Welcome to our dedicated page for CRDX news (Ticker: CRDX), a resource for investors and traders seeking the latest updates and insights on CRDX stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CRDX's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CRDX's position in the market.
Credex Corporation (OTC Pink: CRDX) has appointed Robin McVey as its new CEO, effective December 2, 2021, following the resignation of former CEO Lawrence Taube, who will remain on the board and serve as CFO until a replacement is found. McVey brings extensive experience from previous roles at Wesley Financial Group and ADT Inc., and aims to enhance Credex’s mission in the CBD industry. Additionally, Mark and Todd Nichols have been appointed as new board members, further strengthening the leadership team.
The Cannabis Depot Holding Corp (CDHC) acquired 99.2% of Credex Corporation's voting securities on June 17, 2021. This strategic move aims to bolster CDHC's goal of becoming a leading vertically integrated cannabis company in Colorado. CDHC plans to purchase three recreational dispensaries, with anticipated sales exceeding $20 million for 2021, and acquire 10 cannabis cultivators with a projected annual plant count of over 33,000. These acquisitions will enable CDHC to access public capital markets, subject to regulatory approvals.
